Journal of Pulmonology and Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pulmonology and Clinical Research 44 7897 074717

Rapid Communication - Journal of Pulmonology and Clinical Research (2025) Volume 8, Issue 3

Global respiratory challenges: Infections and environment.

Ayesha Karim*

Department of Pulmonology, University of Pune, India

*Corresponding Author:
Ayesha Karim
Department of Pulmonology
University of Pune, India.
E-mail: ayesha.karim@puneuniv.ac.in

Received : 01-May-2025, Manuscript No. AAJPCR-25-210; Editor assigned : 05-May-2025, PreQC No. AAJPCR-25-210(PQ); Reviewed : 23-May-2025, QC No AAJPCR-25-210; Revised : 03-Jun-2025, Manuscript No. AAJPCR-25-210(R); Published : 12-Jun-2025 , DOI : 10.35841/aajpcr-8.3.210

Citation: Karim A. Global respiratory challenges: Infections and environment. J Pulmonol Clin Res. 2025;08(03):210.

Visit for more related articles at Journal of Pulmonology and Clinical Research

Introduction

Global public health faces significant challenges from respiratory diseases, encompassing infectious conditions like tuberculosis (TB) and its severe complications, as well as syndromes like Acute Respiratory Distress Syndrome (ARDS), which can arise from various etiologies. Understanding the epidemiology and burden of these conditions is paramount for developing effective prevention and management strategies. Recent research highlights several key areas, underscoring both persistent and emerging threats to respiratory health worldwide. Acute Respiratory Distress Syndrome (ARDS) occurring with tuberculosis carries significant mortality, often requiring mechanical ventilation. This substantial burden of TB-associated ARDS contributes to severe outcomes, emphasizing the need for early diagnosis and aggressive management strategies [1].

The global burden of tuberculosis itself remains a pressing issue, with specific demographic vulnerabilities. An age-period-cohort analysis maps the global and regional tuberculosis burden among older adults, revealing that older populations face a disproportionately high burden of TB. This underscores the necessity for targeted interventions and prevention strategies tailored for this vulnerable demographic to effectively reduce disease incidence and mortality [2].

Complementing this, a systematic analysis for the Global Burden of Disease Study provides a detailed breakdown of global, regional, and national incidence, prevalence, and deaths of tuberculosis by age and sex from 1990 to 2019, revealing persistent disparities and guiding public health efforts to reduce the TB burden worldwide [7].

Furthermore, Latent Tuberculosis Infection (LTBI) is a critical reservoir for active TB, influencing global disease control efforts. A comprehensive global perspective on the epidemiology of LTBI emphasizes its widespread prevalence and the ongoing challenges in identifying and treating infected individuals to prevent future disease outbreaks [9].

Beyond susceptible populations, the challenge of drug resistance in TB is significant. Multidrug-resistant tuberculosis (MDR-TB) poses a severe public health threat, particularly in Southeast Asia. A systematic review identifies key epidemiological trends and risk factors contributing to MDR-TB prevalence in the region, offering crucial insights for developing targeted control programs and improving patient outcomes [4].

ARDS itself is a major global health challenge, irrespective of its underlying cause. An analysis from the Global Burden of Disease Study highlights the substantial incidence, prevalence, and mortality associated with ARDS across different regions and demographics, providing a comprehensive understanding of its burden and informing public health priorities [3].

The epidemiology of ARDS is also closely linked to specific infectious outbreaks. For example, COVID-19 has profoundly impacted healthcare systems globally, with many severe cases developing ARDS. One study examines the epidemiology of ARDS in critically ill COVID-19 patients within intensive care units, detailing patient characteristics, management approaches, and important long-term outcomes, providing essential data for post-pandemic care strategies [5].

Similarly, severe influenza can lead to ARDS, a life-threatening complication. A review explores the epidemiology and underlying molecular mechanisms of ARDS in severe influenza cases, offering insights into disease pathogenesis and potential therapeutic targets for improving patient outcomes [8].

Emerging pathogens also contribute to the respiratory disease landscape. Non-tuberculous mycobacteria (NTM) pulmonary disease is an emerging global health concern. A systematic review provides an updated overview of the global epidemiology of NTM pulmonary disease, highlighting variations in prevalence across different regions and the increasing clinical significance of these infections, which often mimic tuberculosis [6].

Finally, environmental factors significantly influence respiratory health. Ambient particulate matter pollution is a major environmental risk factor for chronic respiratory diseases. A study quantifies the global burden of these conditions attributable to air pollution from 1990 to 2019, highlighting the pervasive impact of environmental factors on lung health and the urgent need for air quality interventions [10].

This collection of research paints a comprehensive picture of the multifaceted nature of respiratory diseases, their burden, and the critical need for integrated public health responses.

Conclusion

The provided research highlights several critical global health challenges. Tuberculosis (TB) remains a major concern, especially in older adults and as a Multidrug-Resistant (MDR-TB) strain prevalent in regions like Southeast Asia. Studies emphasize the overall global, regional, and national burden of TB, including incidence, prevalence, and mortality across different demographics. Latent Tuberculosis Infection (LTBI) is identified as a significant reservoir, posing challenges for control efforts. Acute Respiratory Distress Syndrome (ARDS) is another key focus, with research detailing its global burden, incidence, prevalence, and mortality. ARDS is shown to be a severe complication in various conditions, including TB-associated ARDS, COVID-19, and severe influenza, often requiring Intensive Care Units (ICUs) and leading to significant mortality. Beyond these direct infections, the data also covers the rising concern of Non-Tuberculous Mycobacteria (NTM) pulmonary disease, which often mimics TB and presents a growing global epidemiological challenge. Environmental factors also play a role, with studies quantifying the global burden of chronic respiratory diseases attributable to ambient particulate matter pollution. Overall, this collection of studies underscores the complex interplay of infectious diseases, environmental factors, and demographic vulnerabilities, pointing to the urgent need for targeted diagnostic, management, and public health intervention strategies to mitigate severe outcomes and reduce global disease burdens. These findings underscore the importance of early diagnosis and aggressive management in reducing the severe impact of these conditions.

References

References

    1. M NV, A AK, I UR. Acute Respiratory Distress Syndrome Associated with Tuberculosis: A Systematic Review and Meta-Analysis. Ann Med Surg (Lond). 2023;85(10):4945-4954.

Indexed at, Google Scholar, Crossref

    1. Yu-Fang X, Xue-Song Y, Xiao-Xiao S. Global, regional, and national tuberculosis burden in older adults: An age-period-cohort study. J Infect. 2023;87(1):56-65.

Indexed at, Google Scholar, Crossref

    1. Jianan L, Wenbo C, Yi H. Global, regional, and national burden of acute respiratory distress syndrome from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019. Crit Care. 2023;27(1):228.

Indexed at, Google Scholar, Crossref

    1. Thuzar L, Pyae SK, Hnin PA. Epidemiological Trends and Risk Factors for Multidrug-Resistant Tuberculosis in Southeast Asia: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(21):6418.

Indexed at, Google Scholar, Crossref

    1. Yuancheng L, Min S, Haixia Z. Epidemiology of ARDS and long-term outcomes for patients with COVID-19 in ICUs. Crit Care. 2022;26(1):226.

Indexed at, Google Scholar, Crossref

    1. Matthew GJ, Matthew WO, Elizabeth PL. Global epidemiology of non-tuberculous mycobacteria pulmonary disease: a systematic review. Lancet Infect Dis. 2023;23(12):e503-e514.

Indexed at, Google Scholar, Crossref

    1. Jianing S, Yunhua M, Min M. Global, regional, and national incidence, prevalence, and deaths of tuberculosis by age and sex, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(8):e653-e666.

Indexed at, Google Scholar, Crossref

    1. Bo Z, Chengdong H, Wei L. Epidemiology and molecular mechanisms of acute respiratory distress syndrome in severe influenza. Respir Res. 2022;23(1):161.

Indexed at, Google Scholar, Crossref

    1. Manjiri SJ, Michael GO, Jason ES. Epidemiology of Latent Tuberculosis Infection: A Global Perspective. Semin Respir Crit Care Med. 2022;43(4):524-531.

Indexed at, Google Scholar, Crossref

    1. Min M, Yuan Y, Yunhua M. Global, regional, and national burden of chronic respiratory diseases due to ambient particulate matter pollution, 1990-2019. Environ Res. 2022;213:113645.

Indexed at, Google Scholar, Crossref

Get the App